- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT06851988
Pode exercer melhorar a imunossensenescência e, assim, reduzir a recaída em pacientes com câncer de cabeça e pescoço
Through the implementation of this three-year project, investigators expect to find a safe and effective exercise prescription for patients with oral cancer after surgery. The findings will encourage and promise and add further support to the concept that exercise prescription is worth implementation as part of care for the patients with head and neck cancer.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Cancer patients have theoretically returned to a disease-free state after receiving curative anticancer therapy, but even after receiving adjuvant concurrent chemoradiotherapy, it does not ideally prevent all cancer recurrences. For that, several guidelines recommend that cancer survivors participate in regular exercise. Exercise has been thought to be associated with improved outcomes and mortality in healthy individuals as well as in certain cancer populations. However, while the most robust evidence has been demonstrated in patients with prostate, breast and colorectal cancers, the effectiveness of exercise interventions in Head and Neck cancer survivors remains inadequately understood.
Aging of the immune system (so-called immunosenescence) has long been known to increase the risk of infection, cancer, chronic inflammatory diseases and age-related multi-morbidity in humans. In the literature, patients with oral cavity cancer are also believed to have the phenomenon of immune aging (immunosenescence). One of the mechanisms that maintain cellular homeostasis and prevent immunosenescence-related damage is autophagy, a cell-survival mechanism, and it has been proposed as one of the most powerful antiaging therapies. Regular exercise can reestablish autophagy, probably through AMP-activated protein kinase activation, and help in reducing the age-related senescence diseases. At present, many research teams in cancer centers are trying to design large-scale prospective trials to answer whether the intervention of exercise can avoid cancer occurrence, health promotion in survivors, and prevention of recurrence.
This project focuses on the integration of the basic and clinical research. The multidisciplinary research team consists of members from the Department of Hematology and Oncology and Department of Rehabilitation of the New Taipei City Tucheng Hospital and Linkou Chang Gung Memorial Hospital. The main purpose of this three-year project is to investigate whether high-intensity interval training (HIIT) along with resistance exercise intervention, which could reduce the recurrence rate by ameliorating immunosenescence on patients with head and neck cancer. The main tasks order by year of this project are as the following: (1) investigating the differences of immunosenescence indicators in blood with before and after conducting eight weeks of HIIT along with resistance exercise training for patients with head and neck cancer (1st year plan); (2) recruiting new subjects, gathering the physical activity at home and the cancer recurrence rate for first-year subjects, investigating the differences of immunosenescence indicators and immune indicators in the peripheral blood, and examining the clinical effectiveness of exercise training (2nd year plan); (3) Tracking the clinical data and research materials for subjects recruited during the first and second years (3rd year plan). Through the implementation of this three-year project, investigators expect to find a safe and effective exercise prescription for patients with oral cancer after surgery. The findings will provide promising evidence and add further support to the concept that exercise prescription is worth implementation as part of care for the patients with head and neck cancer.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Wan-Chin Kuo
- Número de telefone: 3708 03-3196200
- E-mail: troublefup6@cgmh.org.tw
Estude backup de contato
- Nome: Kuo
Locais de estudo
-
-
-
New Taipei City, Taiwan, 23652
- Recrutamento
- TuCheng Hospital
-
Contato:
- Chia-Hsun Hsieh, PhD
- Número de telefone: 0975366137
- E-mail: wisdom5000@cgmh.org.tw
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Age ≥20
- Pathology:Squamous cell carcinoma
- Need CCRT treatment
- ECOG PS<2
- Agree with blood drawing, excise training, questionnaire
Exclusion Criteria:
- ECOG PS≥2
- Unable to tolerate basic exercise, or CCRT treatment
- Mental illness or any medical illness or concurrent illness that may be aggravated by exercise training or unmanageable
- Any medical condition that unsuitable for exercise
- Disagree to trial procedures: exercise, blood draws, questionnaire
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Outro
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Head and Neck patient after CCRT treatment with HIIT training-Experimental group
After CCRT treatment 4-5 week arrange HIIT training for patient. Two to three times a week ,total 24-36 times. keep follow the PFS and OS |
After CCRT treatment 4-5 week arrange HIIT excise for patient two to three times a week 24-36 times. And record of physical activities at home. According to the record set goal to acheive. After CCRT treatment 4-5 week arrange HIIT excise for patient two to three times a week 24-36 times. |
|
Sem intervenção: Head and Neck patient after CCRT treatment-Experimental group
keep follow the PFS and OS |
|
|
Experimental: Head and Neck patient after CCRT treatment with HIIT training-Validation group
After CCRT treatment 4-5 week arrange HIIT training for patient. Two to three times a week ,total 24-36 times. keep follow the PFS and OS |
After CCRT treatment 4-5 week arrange HIIT excise for patient two to three times a week 24-36 times. And record of physical activities at home. According to the record set goal to acheive. After CCRT treatment 4-5 week arrange HIIT excise for patient two to three times a week 24-36 times. |
|
Sem intervenção: Head and Neck patient after CCRT treatment-Validation group
keep follow the PFS and OS |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
percent of participants with phenoage and age
Prazo: baseline before CCRT
|
To evaluate the phenoage acceleration by calculating differencehe of patients with phenoage and age. |
baseline before CCRT
|
|
percent of participants with phenoage and age
Prazo: 1 months after the completion of CCRT
|
To evaluate the phenoage acceleration by calculating differencehe of patients with phenoage and age. |
1 months after the completion of CCRT
|
|
percent of participants with phenoage and age
Prazo: 6 months after the completion of CCRT
|
To evaluate the phenoage acceleration by calculating differencehe of patients with phenoage and age. |
6 months after the completion of CCRT
|
|
percent of participants with phenoage and age
Prazo: 9 months after the completion of CCRT
|
To evaluate the phenoage acceleration by calculating differencehe of patients with phenoage and age. |
9 months after the completion of CCRT
|
|
Peak VO2 (ml/min/kg) of participants
Prazo: baseline before CCRT
|
To record the Peak VO2 (ml/min/kg) of participants and to evulate the effectiveness of exercise training |
baseline before CCRT
|
|
Peak VO2 (ml/min/kg) of participants
Prazo: 1 months after the completion of CCRT
|
To record the Peak VO2 (ml/min/kg) of participants and to evulate the effectiveness of exercise training.The higher scores mean a better outcome. |
1 months after the completion of CCRT
|
|
Peak VO2 (ml/min/kg) of participants
Prazo: 6 months after the completion of CCRT
|
To record the Peak VO2 (ml/min/kg) of participants and to evulate the effectiveness of exercise training.The higher scores mean a better outcome. |
6 months after the completion of CCRT
|
|
Peak VO2 (ml/min/kg) of participants
Prazo: 9 months after the completion of CCRT
|
To record the Peak VO2 (ml/min/kg) of participants and to evulate the effectiveness of exercise training. The higher scores mean a better outcome. |
9 months after the completion of CCRT
|
|
Questionnaire of European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43)
Prazo: baseline before CCRT
|
To assese the quality of life at the Head and Neck participants and evulate the effectiveness of exercise training.The minimum value is 43 and the maximum value is 172. The higher scores mean a worse outcome. |
baseline before CCRT
|
|
Questionnaire of European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43)
Prazo: 1 month after the completion of CCRT
|
To assese the quality of life at the Head and Neck participants and evulate the effectiveness of exercise training.The minimum value is 43 and the maximum value is 172. The higher scores mean a worse outcome. |
1 month after the completion of CCRT
|
|
Questionnaire of European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43)
Prazo: 6 month after the completion of CCRT
|
To assese the quality of life at the Head and Neck participants and evulate the effectiveness of exercise training.The minimum value is 43 and the maximum value is 172. The higher scores mean a worse outcome. |
6 month after the completion of CCRT
|
|
Questionnaire of European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43)
Prazo: 9 month after the completion of CCRT
|
To assese the quality of life at the Head and Neck participants and evulate the effectiveness of exercise training.The minimum value is 43 and the maximum value is 172. The higher scores mean a worse outcome. |
9 month after the completion of CCRT
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Cadeira de estudo: Chia-Hsun Hsieh, New Tipei City Tucheng Hospital
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 202201332B0
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .